Buscador de la actividad científica de IrsiCaixa | 57 | IrsiCaixa

Filtrar por grupo de investigación

Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-infected patients with virological failure.

Comparison of lipid profile with nevirapine versus atazanavir/ritonavir, both combined with tenofovir DF and emtricitabine (TDF/FTC), in treatment-naive HIV-1-infected patients: ARTEN study week 48 results.

Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV-Infected patients in Spain, 1997-2006.

Differences in Health Care of HIV-infected patients across Europe.

Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.

Effects of HAART on Vaccine-Induced Humoral Immunity in HIV-infected Adults

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.

Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study.

Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4

Fosamprenavir (GW433908)/ ritonavir in HIV-infected patients: efficacy and safety results from the Spanish expanded access program.

Impulsado por:

Fundación 'La Caixa'

Miembro de:

Con la colaboración de: